1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer
Open Access
- 4 July 2011
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 22 (9) , 1973-1980
Abstract
The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.Keywords
This publication has 43 references indexed in Scilit:
- European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung CancerJournal of Clinical Oncology, 2010
- Selective Nodal Irradiation on Basis of 18FDG-PET Scans in Limited-Disease Small-Cell Lung Cancer: A Prospective StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive diseaseAnnals of Oncology, 2010
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trialThe Lancet Oncology, 2009
- Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancerLung Cancer, 2007
- Prophylactic Cranial Irradiation in Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2007
- Similar outcome of elderly patients in Intergroup Trial 0096Cancer, 2000
- Predictors of survival following relapse or progression of small cell lung cancer. Southwest oncology group study 8605 report and analysis of recurrent disease data baseCancer, 1993